Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03978455 · ClinicalTrials.gov registry record
A Pilot Study of the Learn, Connect, and Quit Mobile Application
A clinical trial, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- 16
- Enrollment target
NCT03978455: Completed study, sponsored by University of Wisconsin, Madison.
NCT03978455 is a clinical trial that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 16 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03978455 has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- 16 participants
- Enrollment target
Study Summary
This research study aims to develop and test the effectiveness of a mobile application for patients who smoke to use while waiting in the clinic exam room to see their provider. The application will present patients with a variety of videos designed to increase their engagement in evidence-based smoking cessation treatment and offer them action steps to engage in smoking-related treatment or discussions with their provider.
Primary Outcome
Total minutes spent watching videos presented on the Learn, Connect, and Quit Mobile Application
Interventions
- BEHAVIORAL Learn, Connect, and Quit Mobile Application
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2019-06-18 |
| Est. Completion | 2019-12-19 |
What the finished NCT03978455 record still lists
NCT03978455 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 16 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Learn, Connect, and Quit Mobile Application is the first listed.
NCT03978455 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03978455 about?
NCT03978455 is a clinical study titled "A Pilot Study of the Learn, Connect, and Quit Mobile Application". This research study aims to develop and test the effectiveness of a mobile application for patients who smoke to use while waiting in the clinic exam room to see their provider. The application will present patients with a variety of videos designed to increase their engagement in evidence-based smo...
What is the current status of trial NCT03978455?
This trial is currently completed. The enrollment target is 16 participants. The study started on 2019-06-18. Estimated completion is 2019-12-19.
What interventions are being tested in trial NCT03978455?
The interventions under investigation include: Learn, Connect, and Quit Mobile Application (BEHAVIORAL).
Who is sponsoring clinical trial NCT03978455?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02422641 · 16 participants · Phase 2
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
- NCT02851758 · 16 participants · NA
Transplantation of Autologously Derived Mitochondria Following Ischemia
- NCT03291028 · 16 participants
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
- NCT03425526 · 16 participants · Phase 1
Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI